UK woman killed by rare IVF risk, Ovarian Hyperstimulation Syndrome
By BBC News,
BBC News
| 04. 13. 2005
Temilola Akinbolagbe, 33, from Plumstead, south London, collapsed at a bus stop after developing Ovarian Hyperstimulation Syndrome (OHSS).
The potentially fatal form of the condition affects about one per cent of women undergoing IVF, although a less severe form is more common.
Experts believe this was the first such death from OHSS in the UK.
Mild and moderate forms of OHSS have been reported to affect up to 20% of women undergoing ovarian induction, which mimics the production of normal hormones.
It is believed there have been three other deaths from the condition in the last 30 years.
Mrs Akinbolagbe, from Plumstead, south London, started to feel ill after receiving fertility treatment.
She was taken to hospital immediately, but suffered a massive heart attack.
Mrs Akinbolagbe's life support machine was turned off five days later.
Her husband, Samuel Ifaturoti, said his wife had been "very positive" about the fertility treatment.
'Not a particular risk'
Gynaecologist John Parsons said staff at Kings College Hospital, where she had received her fertility treatment, were all shocked by Mrs Akinbolagbe's death.
He said: "We...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...